Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/26499
Title: Metamizole versus ibuprofen at home after day surgery: study protocol for a randomised controlled trial
Authors: STESSEL, Bjorn 
Boon, Michiel
Joosten, Elbert A.
Ory, Jean-Paul
EVERS, Stefan 
van Kuijk, Sander M. J.
Dubois, Jasperina
Hoofwijk, Daisy
Jamaer, Luc
Buhre, Wolfgang F. F. A.
Issue Date: 2016
Source: TRIALS, 17 (Art N° 471)
Abstract: Background: Postoperative pain and, in a more extended perspective, quality of recovery (QOR) should be considered the principal endpoints after day surgery. Non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol are a cornerstone of pain treatment after painful day surgery. Nevertheless, NSAIDs are not always sufficiently effective, have numerous contraindications, and consequently are not suitable in up to 25 % of all patients. Metamizole is a non-opioid compound with a favourable gastrointestinal, cardiovascular and cerebrovascular profile compared to NSAIDs. The aim of this study is to assess if a combination of metamizole and paracetamol is non-inferior to a combination of ibuprofen and paracetamol in the treatment of acute postoperative pain at home after painful day case surgery. In addition, we aim to assess and compare quality of recovery (QOR) profiles of both groups. Methods/Design: This is an investigator-initiated, double-blind, randomised controlled, non-inferiority trial. A total of 200 patients undergoing elective haemorrhoid surgery, arthroscopic shoulder or knee surgery, or inguinal hernia repair in a day care setting will be randomised to receive either a combination of metamizole and paracetamol (MP) or a combination of ibuprofen and paracetamol (IP). Participants will take study medication orally for 4 days. Primary endpoints are average postoperative pain intensity measured by an 11-point Numeric Rating Scale at postoperative day 1 and QOR profile measured by the Functional Recovery Index (FRI), the 1-item Global Surgical Recovery (GSR) index and the EuroQol (EQ-5D) questionnaire at days 1, 2, 3, 4, 7, 14 and 28 postoperatively. Secondary outcomes include compliance with study medication, adverse effects of study medication, use of rescue medication and satisfaction with study medication, surgery and hospital care and telephone follow-up. Discussion: This study will provide clinical evidence on the analgesic efficacy and safety of a combination of metamizole and paracetamol in treating postoperative pain at home after painful day surgery. This study may also provide an insight into QOR profile after four different types of surgery and into the interrelationship between three different instruments used to assess QOR.
Keywords: ambulatory surgery; day surgery; metamizole; dipyrone; NSAID; recovery; Functional Recovery Index; EQ-5D; acute pain; postoperative pain
Document URI: http://hdl.handle.net/1942/26499
e-ISSN: 1745-6215
DOI: 10.1186/s13063-016-1586-8
ISI #: 000384847600008
Rights: © 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Stessel.pdfPublished version758.98 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

3
checked on Sep 5, 2020

WEB OF SCIENCETM
Citations

6
checked on Apr 14, 2024

Page view(s)

84
checked on Sep 5, 2022

Download(s)

116
checked on Sep 5, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.